Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Glenveigh Medical digoxin antidote gets orphan drug designation

Feb. 16, 2012

Recruitment begins in phase II ISIS-APOCIIIRx trial

Feb. 16, 2012

Trimel provides update on intranasal gel for female anorgasmia

Feb. 16, 2012

Columbia Laboratories transfers progesterone vaginal gel NDA

Feb. 15, 2012

New phase III data support once-weekly exenatide use for diabetes type 2

Feb. 15, 2012

Amarin gives update on FDA's review of AMR-101 NDA

Feb. 15, 2012

Amylin Pharmaceuticals launches Bydureon in U.S.

Feb. 14, 2012

Karo Bio discontinues development of eprotirome

Feb. 14, 2012

New bile acid GPBA receptor agonists developed at Roche

Feb. 14, 2012

Antisense Therapeutics provides update on second-generation product

Feb. 14, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...